Literature DB >> 20333451

siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.

Yuwei Wang1, David W Grainger.   

Abstract

PURPOSE: To demonstrate the ability of small interfering (si)RNA targeting the cell receptor, RANK, to control osteoclast function in cultures of both primary and secondary osteoclasts and their precursor cells.
METHODS: siRNA targeting RANK was transfected into both RAW264.7 and primary bone marrow cell cultures. RANK knock-down by siRNA and functional inhibition were assessed in both mature osteoclast and their precursor cell cultures. RANK mRNA message and protein expression after the transfections were analyzed by PCR and Western blot, respectively. Off-target effects were assessed. The inhibition of osteoclast formation was evaluated using tartrate-resistant acid phosphatase (TRAP) assay, and subsequent bone resorption was determined by resorption pit assay.
RESULTS: Both osteoclasts and osteoclast precursors can be targeted by siRNA in serum-containing media. Delivery of siRNA targeting RANK to both RAW 264.7 and primary bone marrow cell cultures produces short term repression of RANK expression without off-targeting effects, and significantly inhibits both osteoclast formation and bone resorption. Moreover, data support successful RANK knock-down by siRNA specifically in mature osteoclast cultures.
CONCLUSIONS: RANK is demonstrated to be an attractive target for siRNA control of osteoclast activity, with utility for development of new therapeutics for low bone mass pathologies or osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333451      PMCID: PMC2885461          DOI: 10.1007/s11095-010-0099-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  55 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 2.  The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?

Authors:  Peyton Hughes; Damian Marshall; Yvonne Reid; Helen Parkes; Cohava Gelber
Journal:  Biotechniques       Date:  2007-11       Impact factor: 1.993

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.

Authors:  P J Kostenuik; C Capparelli; S Morony; S Adamu; G Shimamoto; V Shen; D L Lacey; C R Dunstan
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

5.  Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.

Authors:  R L Lees; V K Sabharwal; J N Heersche
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

Review 6.  Denosumab: anti-RANKL antibody.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

7.  Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.

Authors:  Ryotaro Iwasaki; Ken Ninomiya; Kana Miyamoto; Toru Suzuki; Yuiko Sato; Hiromasa Kawana; Taneaki Nakagawa; Toshio Suda; Takeshi Miyamoto
Journal:  Biochem Biophys Res Commun       Date:  2008-10-24       Impact factor: 3.575

Review 8.  The challenge of establishing preclinical models for segmental bone defect research.

Authors:  Johannes C Reichert; Siamak Saifzadeh; Martin E Wullschleger; Devakara R Epari; Michael A Schütz; Georg N Duda; Hanna Schell; Martijn van Griensven; Heinz Redl; Dietmar W Hutmacher
Journal:  Biomaterials       Date:  2009-02-10       Impact factor: 12.479

Review 9.  Management of Paget's disease of bone.

Authors:  A L Langston; S H Ralston
Journal:  Rheumatology (Oxford)       Date:  2004-06-08       Impact factor: 7.580

10.  Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.

Authors:  Louis C Gerstenfeld; Daniel J Sacks; Megan Pelis; Zachary D Mason; Dana T Graves; Mauricio Barrero; Michael S Ominsky; Paul J Kostenuik; Elise F Morgan; Thomas A Einhorn
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

View more
  13 in total

1.  Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.

Authors:  Yuwei Wang; Alexandra Panasiuk; David W Grainger
Journal:  Mol Pharm       Date:  2011-01-21       Impact factor: 4.939

Review 2.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

Review 3.  Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.

Authors:  Julia E Samorezov; Eben Alsberg
Journal:  Adv Drug Deliv Rev       Date:  2014-11-29       Impact factor: 15.470

4.  Cell-cell signaling in co-cultures of macrophages and fibroblasts.

Authors:  Dolly J Holt; Lisa M Chamberlain; David W Grainger
Journal:  Biomaterials       Date:  2010-10-06       Impact factor: 12.479

5.  Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.

Authors:  Sabine Hellwig; Chandra V Miduturu; Shigeru Kanda; Jianming Zhang; Panagis Filippakopoulos; Eidarus Salah; Xianming Deng; Hwan Geun Choi; Wenjun Zhou; Wooyoung Hur; Stefan Knapp; Nathanael S Gray; Thomas E Smithgall
Journal:  Chem Biol       Date:  2012-04-20

6.  Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.

Authors:  Lin Cong; Chaoyi Zhang; Guanjun Tu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Multinucleated giant cells from fibroblast cultures.

Authors:  Dolly J Holt; David W Grainger
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

8.  Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials.

Authors:  Yuwei Wang; Kenny K Tran; Hong Shen; David W Grainger
Journal:  Biomaterials       Date:  2012-09-03       Impact factor: 12.479

Review 9.  Ribonucleic acid interference induced gene knockdown.

Authors:  Sruthima N V S Gottumukkala; C D Dwarakanath; Sabitha Sudarsan
Journal:  J Indian Soc Periodontol       Date:  2013-07

Review 10.  The deep-sea natural products, biogenic polyphosphate (Bio-PolyP) and biogenic silica (Bio-Silica), as biomimetic scaffolds for bone tissue engineering: fabrication of a morphogenetically-active polymer.

Authors:  Xiaohong Wang; Heinz C Schröder; Qingling Feng; Florian Draenert; Werner E G Müller
Journal:  Mar Drugs       Date:  2013-03-08       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.